Revenue Growth Reinforces CEG's Narrative, but Timing and Valuation Keep Rating at WAIT

What happened

Zacks highlights rising revenues, long-term nuclear PPAs, and fleet extensions as drivers of stronger, more predictable growth for Constellation Energy. The DeepValue report acknowledges these strengths, noting the 55 GW portfolio, 80% Fortune 100 customer reach, and $11.855 billion in remaining performance obligations. However, the report maintains a WAIT rating because the stock at $266.60 already prices in much of the premium nuclear contracting, Illinois uprates, and Crane restart progress that management frames as 2029 upside rather than base earnings. Recent financials show mixed execution: Q2 2026 free cash flow was negative $118 million despite $1.128 billion of operating cash flow due to heavy capex, while nuclear PTC and state-program offsets dampened reported earnings. Key milestones to monitor are additional named PPAs beyond the current 920 MW, an on-time Q4 2026 Illinois uprate filing, and clearer Crane interconnection resolution by early 2027.

Implication

The current price embeds optimistic assumptions about nuclear monetization that have not yet translated into reported earnings, leaving limited margin of safety. Investors should require concrete proof of broadening customer adoption—such as cumulative incremental nuclear PPAs exceeding 1.5 GW by Q1 2027—before increasing exposure. A failure to file the Illinois uprate application on schedule or further Crane interconnection delays would undermine the bull case and could push the stock toward the $230 bear scenario. Conversely, a decisive resolution of those milestones combined with a pullback to the $235 entry zone would improve risk-reward asymmetry. Until such signals emerge, the prudent strategy is to hold existing positions without adding at current levels and to trim above $305 if the stock runs on narrative rather than fundamentals.

Thesis delta

The Zacks article reinforces the existing bullish narrative around revenue growth and long-term PPAs but does not introduce new evidence that addresses the key timing risks. Our thesis remains unchanged: Constellation's asset quality and commercial moat are real, yet the stock is fairly valued at current levels because premium contracting, uprates, and Crane restart are still future optionality. We continue to rate CEG a WAIT with an attractive entry at $235 and trim level at $305.